Pediatric Neurocysticercosis: Usefulness of Antibody Response in Cysticidal Treatment Follow-Up

Serum and urine samples were collected from 33 NCC patients before the albendazole treatment, 3–6 and 12 months PT. At 3 months PT, 24 (72.7%) patients had no detectable CT/MRI lesions and 9 (27.2%) patients had persistent lesions. Antibody response to crude soluble extract (CSE), excretory secretor...

Descripción completa

Detalles Bibliográficos
Autores principales: Atluri, Venkata Subba Rao, Gogulamudi, Venkateswara Reddy, Singhi, Pratibha, Khandelwal, Niranjan, Parasa, Lakshmana Swamy, Malla, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158118/
https://www.ncbi.nlm.nih.gov/pubmed/25215297
http://dx.doi.org/10.1155/2014/904046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158118/
https://www.ncbi.nlm.nih.gov/pubmed/25215297
http://dx.doi.org/10.1155/2014/904046

Ejemplares similares